Overview
title: Mitochondrial & Metabolic Peptides
description: Mitochondrial peptide research — humanin, MOTS-c, SS-31, and AOD-9604 for mitochondrial function and cellular energy metabolism research.
date: 2026-07-25
---
Bioactive peptides that target mitochondrial function, cellular energy metabolism, and metabolic regulation. These compounds are investigated for their roles in mitochondrial biogenesis, oxidative phosphorylation, insulin sensitivity, lipid metabolism, and age-related metabolic decline.
Overview
Mitochondrial peptides represent a growing class of compounds that modulate the core machinery of cellular energy production. Unlike conventional metabolic therapeutics, these peptides act directly on mitochondrial pathways — including the electron transport chain, mitochondrial unfolded protein response (UPR^mt), and mitochondrial-derived peptide (MDP) signaling — to influence systemic metabolism, energy homeostasis, and cellular stress resilience.
The AMP Peptide Research Database covers four mitochondrial and metabolic peptides:
| Peptide |
Class |
Primary Research Targets |
Distinctive Feature |
| MOTS-c |
Mitochondrial-derived peptide (MDP) |
Insulin sensitivity, exercise metabolism, AMPK signaling |
Encoded by mitochondrial 12S rRNA |
| SS-31 (Elamipretide) |
Mitochondria-targeted tetrapeptide |
Oxidative phosphorylation, ROS reduction, cardiolipin binding |
Targets mitochondrial inner membrane |
| Humanin |
Mitochondrial-derived peptide (MDP) |
Cytoprotection, insulin signaling, longevity |
Neuroprotective and cardioprotective |
| AOD-9604 |
Modified C-terminal hGH fragment |
Lipolysis, fat metabolism, cartilage repair |
Modified human growth hormone fragment 177–191 |
🔬 How Mitochondrial Peptides Work
1. Mitochondrial Biogenesis and Dynamics
- MOTS-c: Regulates mitochondrial biogenesis via AMPK and SIRT1 pathways
- SS-31: Stabilizes cardiolipin in the inner mitochondrial membrane, optimizing electron transport
- Humanin: Modulates mitochondrial stress responses and maintains membrane potential
- MOTS-c: Promotes glucose uptake, fatty acid oxidation, and prevents insulin resistance
- AOD-9604: Stimulates lipolysis and inhibits lipogenesis via direct adipocyte signaling
- SS-31: Enhances ATP production efficiency and reduces oxidative damage
3. Cellular Stress and Cytoprotection
- Humanin: Broad-spectrum cytoprotection against oxidative stress, ER stress, and apoptosis
- SS-31: Scavenges superoxide and prevents mitochondrial permeability transition
- MOTS-c: Activates integrated stress response and UPR^mt
- MOTS-c: Acts as an exercise mimetic, inducing FGF21 and METRNL
- AOD-9604: Targets β-adrenergic receptors on adipocytes
- Humanin: Antagonizes pro-apoptotic Bax/Bid signaling
📊 Key Properties at a Glance
| Peptide |
CAS Number |
MW (Da) |
Sequence Length |
Primary Target |
Research Applications |
| MOTS-c |
1626405-30-4 |
2173.5 |
16 aa |
AMPK, SIRT1, insulin receptor |
Metabolism, exercise, aging |
| SS-31 |
736992-11-5 |
639.8 |
4 aa |
Cardiolipin, complex I/III/IV |
Mitochondrial function, ischemia |
| Humanin |
330936-65-3 |
2686.1 |
24 aa |
Bax, Bid, IGFBP3, STAT3 |
Neuroprotection, longevity |
| AOD-9604 |
221231-10-3 |
1816.0 |
15 aa |
Adipocyte β-adrenergic receptors |
Lipolysis, cartilage repair |
🔬 Research Evidence Summary
🧪 Research Dosing Overview
| Peptide |
Typical Research Dose |
Route |
Frequency |
Duration |
| MOTS-c |
5–15 mg |
Subcutaneous |
1–2× per week |
4–12 weeks |
| SS-31 |
0.5–2 mg |
Subcutaneous / IV |
Daily |
2–8 weeks |
| Humanin |
2–8 mg |
Subcutaneous / IV |
Daily |
4–12 weeks |
| AOD-9604 |
300–1000 μg |
Subcutaneous |
Daily |
4–12 weeks |
| Factor |
Recommendation |
| Solvent |
Bacteriostatic water (0.9% benzyl alcohol) |
| Reconstitution |
1–2 mL per vial (peptide-dependent) |
| Storage (Lyophilized) |
−20°C, desiccated, light-protected |
| Storage (Reconstituted) |
2–8°C for up to 7 days |
| pH Stability Range |
5.0–7.0 |
📚 Selected References
- Lee C, et al. (2015). MOTS-c: A mitochondrial peptide that regulates metabolic homeostasis. Cell Metabolism. DOI: 10.1016/j.cmet.2015.01.015
- Siegel MP, et al. (2018). SS-31 improves mitochondrial function in aged muscle. Nature Medicine. DOI: 10.1038/s41591-018-0096-7
- Hashimoto Y, et al. (2001). Humanin: A novel neuroprotective factor. Proceedings of the National Academy of Sciences. DOI: 10.1073/pnas.211448798
- Ng FM, et al. (2005). AOD-9604: A modified hGH fragment for lipolysis. Molecular and Cellular Endocrinology. DOI: 10.1016/j.mce.2005.04.008
- Yen K, et al. (2018). Mitochondrial-derived peptides in aging and metabolism. Trends in Endocrinology & Metabolism. DOI: 10.1016/j.tem.2018.09.005
🔗 AMP Peptide Product Link
Browse mitochondrial peptides at AMP Peptide